Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03417960 · ClinicalTrials.gov registry record · NA

Accelerated iTBS for Post Partum Depression

A NA study of Postpartum Depression, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03417960: Recruiting NA study of Postpartum Depression, sponsored by Medical University of South Carolina.

NCT03417960 is a NA study of Postpartum Depression that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 40 participants, below the 474-participant average among 47 other Postpartum Depression trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03417960, a NA study of Postpartum Depression, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Study 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigators further aim to characterize the anticipated anti-depressant effect of this treatment paradigm. Study 2: The investigators are studying the feasibility and tolerability of 12 sessions/day of intermittent theta burse (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over 5 days for women with post-partum depression. The investigators aim to compare the two different treatment schedules.

Primary Outcome

Determine feasibility and tolerability of accelerated iTBS for postpartum depression. The investigators hope to retain \>80% of recruited patients (feasibility) and reach a full treatment dose of 120%rMT in \>80% of enrolled women (tolerability).

Conditions Studied

Postpartum Depression

Interventions

  • DEVICE iTBS

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2018-01-24
Est. Completion 2027-08-30
Phase NA
Medical University of South Carolina

755 total trials

What NCT03417960 shows while recruiting

NCT03417960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 474-participant average among 47 other Postpartum Depression trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 1 intervention - of which iTBS is the first listed.

NCT03417960 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT03417960 about?

NCT03417960 is a clinical study titled "Accelerated iTBS for Post Partum Depression". Study 1: The investigators are studying the feasibility and tolerability of 10x/day intermittent theta burst (excitatory) transcranial magnetic stimulation to the left dorsolateral prefrontal cortex over the course of 6 days for women with post-partum depression. The investigators further aim to cha...

What is the current status of trial NCT03417960?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-01-24. Estimated completion is 2027-08-30.

What conditions does trial NCT03417960 study?

This clinical trial studies the following conditions: Postpartum Depression.

What interventions are being tested in trial NCT03417960?

The interventions under investigation include: iTBS (DEVICE).

Who is sponsoring clinical trial NCT03417960?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03417960 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Postpartum Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03417960's enrollment target sits among peer trials

40 41st of 47 higher than 6 of 47 other Postpartum Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT03417960

Source: ClinicalTrials.gov NCT03417960, the US trial registry maintained by the National Library of Medicine. NCT03417960 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.